Hospitalization trends among children and youths with perinatal human immunodeficiency virus infection, 1990-2002

Pediatric Infectious Disease Journal

Volumn 25, Issue 7, 2006, Pages 628-633

  Bertolli, Jeanne ^a   Hsu, Ho Wen ^b   Sukalac, Thomas ^a   Williamson, John ^a   Peters, Vicki ^c   Frederick, Toni ^d   Rakusan, Tamara A ^e   Ortiz, Idith ^f   Melville, Sharon K ^g   Dominguez, Kenneth ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b State Laboratory Institute   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d Los Angeles County Department of Public Health   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f Puerto Rico Department of Health   (Puerto Rico)

^g TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Antiretroviral therapy; HIV; Hospitalization; Perinatal infection

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; CHILD HOSPITALIZATION; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEGRO; NEWBORN; PERINATAL INFECTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; ETHNIC GROUPS; FEMALE; HIV; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; PERINATOLOGY; PROSPECTIVE STUDIES;

EID: 33745726947     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000220255.14636.b3     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2003: HIV/AIDS surveillance report, vol. 15. Available at: http://www.cdc.gov/hiv/stats/2003SurveillanceReport.htm. Accessed May 15, 2005.
2. Kattan M. Respiratory compromise in children infected with HIV. In: Shearer WT, Hanson IC, eds. Medical Management of HIV in Children. Philadelphia, Pa: Elsevier Science; 2003:193-204.
3. De Martino M, Tovo P-A, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA. 2000;284:190-197.
4. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522-1528.
5. Fleming PL, Ward JW, Karon JM, et al. Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS. 1998;12(suppl A):S55-61.
6. The European Collaborative Study. Hospitalization of children born to human immunodeficiency virus-infected women in Europe. Pediatr Infect Dis J. 1997;16:1151-1156.
7. Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census [letter]. N Engl J Med. 1997;336:1531-1532.
8. Palella FJ, Delaney K, Moorman A, et al. Declining morbidity and mortality among patients with advance immunodeficiency virus infection. N Engl J Med. 1998;13:853-860.
9. The HIV Research Network. Hospital and outpatient health services utilization among HIV-infected patients in care in 1999. J Acquir Immune Defic Syndr. 2002;30:21-26.
10. Lavalle C, Aguilar JCD, Pena F, Estrada-Aguilar JL, Avina-Zubieta JA, Madrazo M. Reduction in hospitalization costs, morbidity, disability, and mortality in patients with AIDS treated with protease inhibitors. Arch Med Res. 2000;31:515-519.
11. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS defining events and hospitalizations in 10 French AIDS reference centres. AIDS. 1997;11:F101-105.
12. Canani RB, Spagnuolo MI, Cirillo P, Guarino A. Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing therapy [letter]. AIDS. 1999;13:1005-1006.
13. Brown MJ, Eastman M, Shenassa ED. Changing trends of HIV-related hospitalizations: a small area analysis in Illinois, 1994-2000. J Community Health. 2003;28:247-255.
14. Sanchez Granados JM, Ramos Amador JT, Fernandez de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2003;22:863-867.
15. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ. 2003;327:1019.
16. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;3:1-12.
17. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47:1-44.
18. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep. 1998;47:1-83.
19. Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1713-1720.
20. Lindegren ML, Byers R, Bertolli J, Dominguez K, Thomas P. Increasing numbers of adolescents living with perinatal HIV-infection in the United States. [Abstract TuPeC3351]. XIII International AIDS Conference, Durban, South Africa, July 2000.
21. Peters V, Liu K-L, Dominguez K, et al, and the PSD Consortium. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000: Pediatric Spectrum of HIV Disease Cohort. Pediatrics. 2003;111:1186-1191.
22. Gaughan DM, Hughes MD, Oleske JM, et al. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004;113:e544-551.
23. Sherer R, Pulvirenti J, Steiglitz K, et al. Hospitalization in Chicago. J Int Assoc Physicians AIDS Care. 2002;1:26-33.
24. McConnell MS, Byers RH, Frederick T, et al. Trends in antiretroviral use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr. 2005;38:488-494.
25. Cunningham WE, Andersen RM, Katz MH, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States.
26. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305-2315.
27. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multi-drug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395.
28. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(suppl 2):S171-S176.